Cancer Research Annual Meeting 2010  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DeYoung, M. P.
Right arrow Articles by Ellisen, L. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DeYoung, M. P.
Right arrow Articles by Ellisen, L. W.
[Cancer Research 66, 9362-9368, October 1, 2006]
© 2006 American Association for Cancer Research


Priority Reports

Tumor-Specific p73 Up-regulation Mediates p63 Dependence in Squamous Cell Carcinoma

Maurice Phillip DeYoung1,2, Cory M. Johannessen1,2, Chee-Onn Leong1,2, William Faquin2,3, James W. Rocco1,2,4 and Leif W. Ellisen1,2

1 Massachusetts General Hospital Cancer Center; 2 Harvard Medical School; 3 Department of Pathology, Massachusetts General Hospital; 4 Division of Surgical Oncology, Massachusetts General Hospital and Massachusetts Eye and Ear Infirmary, Boston, Massachusetts

Requests for reprints: Leif W. Ellisen, Massachusetts General Hospital Cancer Center, GRJ-904, 55 Fruit Street, Boston, MA 02114. Phone: 617-726-4315; E-mail: lellisen{at}partners.org.

p63 is essential for normal epithelial development and is overexpressed in the vast majority of squamous cell carcinomas (SCC). Recent work had shown that {Delta}Np63{alpha} is essential for survival of SCC cells, raising the possibility that the p63 pathway may be an attractive therapeutic target in these tumors. Nevertheless, it is unknown whether a therapeutic window exists for inhibiting p63 in tumor cells versus normal epithelia. Here, we show that SCC cells are uniquely dependent on {Delta}Np63{alpha} for survival, unlike normal p63-expressing epithelial cells, and that dependence is mediated through tumor-specific up-regulation of the related protein p73. In normal primary human keratinocytes, we find that inhibition of endogenous p63 by RNA interference (RNAi) induces p21CIP1 expression, inhibits cell cycle progression, and ultimately promotes cellular senescence. In contrast, p63 inhibition in SCC cells induces proapoptotic bcl-2 family members and rapidly triggers apoptosis. Expression of p73 is low in uncultured basal keratinocytes but is markedly up-regulated in both SCC cell lines and primary tumors in vivo. Whereas p21CIP1 induction following loss of p63 in normal cells is independent of p53 and p73, both proapoptotic gene induction and cell death following p63 RNAi in tumor cells are p73 dependent. Finally, ectopic p73 expression in primary keratinocytes does not affect baseline cell proliferation but is sufficient to trigger cell death following loss of p63. Together, these findings define a specific molecular mechanism of p63 dependence through p73 up-regulation, and they provide a rationale for targeting the p63 pathway as a therapeutic strategy in SCCs. (Cancer Res 2006; 66(19): 9362-8)




This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
Y. Li, M. J. Peart, and C. Prives
Stxbp4 Regulates {Delta}Np63 Stability by Suppression of RACK1-Dependent Degradation
Mol. Cell. Biol., July 15, 2009; 29(14): 3953 - 3963.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. E. Butler, M. B. Moore, S. R. Presnell, H.-W. Chan, N. J. Chalupny, and C. T. Lutz
Proteasome Regulation of ULBP1 Transcription
J. Immunol., May 15, 2009; 182(10): 6600 - 6609.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
W. A. Michaud, A. C. Nichols, E. A. Mroz, W. C. Faquin, J. R. Clark, S. Begum, W. H. Westra, H. Wada, P. M. Busse, L. W. Ellisen, et al.
Bcl-2 Blocks Cisplatin-Induced Apoptosis and Predicts Poor Outcome Following Chemoradiation Treatment in Advanced Oropharyngeal Squamous Cell Carcinoma
Clin. Cancer Res., March 1, 2009; 15(5): 1645 - 1654.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. M. Rosenbluth, D. J. Mays, M. F. Pino, L. J. Tang, and J. A. Pietenpol
A Gene Signature-Based Approach Identifies mTOR as a Regulator of p73
Mol. Cell. Biol., October 1, 2008; 28(19): 5951 - 5964.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
J. M. Rosenbluth and J. A. Pietenpol
The jury is in: p73 is a tumor suppressor after all
Genes & Dev., October 1, 2008; 22(19): 2591 - 2595.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. E. King, R. M. Ponnamperuma, C. Allen, H. Lu, P. Duggal, Z. Chen, C. Van Waes, and W. C. Weinberg
The p53 Homologue {Delta}Np63{alpha} Interacts with the Nuclear Factor-{kappa}B Pathway to Modulate Epithelial Cell Growth
Cancer Res., July 1, 2008; 68(13): 5122 - 5131.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
B. E. Ferguson-Yates, H. Li, T. K. Dong, J. L. Hsiao, and D. H. Oh
Impaired repair of cyclobutane pyrimidine dimers in human keratinocytes deficient in p53 and p63
Carcinogenesis, January 1, 2008; 29(1): 70 - 75.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.